Clinical trials
Phase 2 trials in Brazil with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
163 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 7 |
| 2008 | 3 |
| 2009 | 8 |
| 2010 | 7 |
| 2011 | 9 |
| 2012 | 5 |
| 2013 | 13 |
| 2014 | 10 |
| 2015 | 8 |
| 2016 | 11 |
| 2017 | 15 |
| 2018 | 11 |
| 2019 | 13 |
| 2020 | 12 |
| 2021 | 11 |
| 2022 | 4 |
| 2023 | 8 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 163 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Sao Paulo General Hospital | 17 |
| University of Sao Paulo | 13 |
| Hospital de Clinicas de Porto Alegre | 12 |
| Instituto do Cancer do Estado de São Paulo | 12 |
| Federal University of São Paulo | 9 |
| Universidade Federal de Pernambuco | 8 |
| University of Nove de Julho | 8 |
| Instituto Nacional de Cancer, Brazil | 5 |
| AC Camargo Cancer Center | 4 |
| D'Or Institute for Research and Education | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 9 |
| Pain | 9 |
| Breast Neoplasms | 7 |
| Chronic Pain | 4 |
| Inflammation | 4 |
| Obesity | 4 |
| Prostatic Neoplasms | 4 |
| Rectal Neoplasms | 4 |
| Cocaine-Related Disorders | 3 |
| Colorectal Neoplasms | 3 |
Trials
Showing 1 to 25 of 163. Each trial links to its page on Pharma Observatory.
63 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.